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The polycystic ovarian syndrome is the utmost common 
endocrinopathy state in women. It is related to both reproductive 
and metabolic disorders. The MTHFR gene associated with the 
ovarian follicular action encodes the 5-MTHFR (methylenetetra-
hydrofolate reductase) enzyme, tangled in folate metabolism. 
MTHFR gene C677T polymorphism declines the enzyme activity 
and thus folate deficit and increases the level of homocysteine, 
which affects the progress of oocytes. Here, we evaluated the 
association of MTHFR gene C677T polymorphism with Polycystic 
ovary syndrome (PCOS) in the South Indian cohort of women. 
About 129 PCOS women with following Rotterdam criteria and 90 
women controls were studied. PCR-RFLP technique was carried 
out on all PCOS women in this study. Dissimilarities in hormone 
levels in PCOS patients were detected. MTHFR gene 
polymorphism CC, CT, TT genotype was found to be 74, 16, 9.30% 
in patients correspondingly. However, in controls, it was 44.4, 24, 
31%, respectively. A substantial difference was detected in the 
genotype frequency distributions among the patients and controls. 
Also, allele frequency was shown as 82.95% C allele and 17.83% 
T allele and 56.67%, 43.33% for C, and T allele in controls 
correspondingly. Our results indicate a possible association and 
suggest that MTHFR C677T polymorphism can be used as a 
potential biomarker for PCOS progress in the South Indian women.  
Keywords: Follicle-stimulating hormone, Luteinizing hormone, 
Metabolic syndromes, PCOS 
Polycystic ovarian syndrome (PCOS) is the utmost 
common endocrinopathy state in women. It is related 
to both reproductive as well as metabolic disorders1. 
Nearly, 5 to 10% of women in reproductive age suffer 
from the symptoms of PCOS2. Hirsutism, higher 
androgen levels, insulin resistance, infertility, and 
menstrual dysfunction are noticeable features of 
PCOS3. Abnormal folliculogenesis and gonadotropin 
production, specifically hypersecretion of LH 
(Luteinizing Hormone), may contribute to the 
development of PCOS; these irregularities may arise 
from environmental insults as well as genetic pre-
disposal4. PCOS is inherited as a multifaceted genetic 
characteristic5. Women with PCOS are also vulnerable 
to develop metabolic syndromes, such as hypertension, 
obesity, diabetes, as well as dyslipidemia, which is a 
foremost risk cause for cardiovascular disease6. Studies 
on PCOS genes are mostly focused on the involvement 
of genes in type 2 diabetes, sex hormones, and 
regulators, cardiovascular disease, steroid metabolism 
and biosynthesis, and insulin sensitivity. Even if 
numerous genetic factors comprising mutations and 
polymorphisms to several genes are linked to PCOS 
risk, inheritance mode and the molecular genetics 
mechanisms underlying PCOS risk are not fully 
understood7. Research on PCOS suggests the 
association of various genes, such as follicle-
stimulating hormone receptor gene8, melatonin 
receptor gene9, cytokine gene10, insulin receptor 
substrate-1 gene11, insulin-like factor 3 gene12, fat 
mass, and obesity-associated gene13 are associated with 
causing of PCOS. 
 
Methylenetetrahydrofolate reductase (MTHFR) is 
reported to be a vital regulatory enzyme in 
homocysteine metabolism14. MTHFR gene has two 
functional polymorphisms, such as C677T (rs1801133) 
and A1298C (rs1801131), which reduce the enzyme 
activity by decreasing the concentration of folate in red 
blood cells (RBCs), serum and plasma, and slightly 
increase the total plasma homocysteine (tHcy) 
concentrations15. The MTHFR alters 5,10 methylene-
tetrahydrofolate to 5 methyltetrahydrofolates and 
offers methyl groups for homocysteine in methionine 
production16. Studies on MTHFR polymorphisms 
(C677T and A1298C) in Chinese PCOS women 
suggest that there may be an association of polymorphisms 
and PCOS risk17. MTHFR is connected with the 
ovarian follicular movement18. The 5-MTHFR enzyme, 
which is encoded by gene MTHFR is intricate in folate 
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metabolism besides reduced enzyme activity, and 
consequent changes in homocysteine concentration, 
are associated with C677T polymorphism15. Folate 
deficiency and hyperhomocysteinemia can distress the 
progress of oocyte19. Conferring to studies association 
of MTHFR gene with PCOS established that 
homocysteine levels were advanced in Turkish patients 
with PCOS and that homocysteine levels of patients 
with PCOS were not influenced by MTHFR C677T 
gene polymorphism20. Another study on Poland 
women with metabolic disturbance in PCOS revealed 
that no association in C677T MTHFR gene 
polymorphism21. Qi et al.22 demonstrated that MTHFR 
gene C677T polymorphism is associated with PCOS, 
for which CT and TT genotypes can upsurge the risk 
of PCOS and A1298C polymorphism was not 
associated with the occurrence of PCOS. A Study on 
Egyptian women has also demonstrated the association 
between PCOS and MTHFR gene C677T 
polymorphism23. A meta-analysis of the association of 
PCOS and MTHFR C677T polymorphism revealed 
that there is a strong association in Asian Population24. 
 
MTHFR C677T polymorphism has been studied in 
several populations with positive and negative 
outcomes. Since no such studies were carried 
previously in the South Indian population, here, we 
investigated the potential correlation of PCOS with 
MTHFR C677T polymorphism in South Indian Women. 
 
Material and Methods 
 
Study population 
Our study includes native South Indian cohort, 
PCOS patients (N=129) following 2003 Rotterdam 
Criteria25, and controls (N=90) selected by excluding 
the diagnosis of PCOS according to the 2003 
Rotterdam Criteria exhibiting normal menstrual cycles 
(b32 days), aged group 15-40 years enrolled from 
Sandhya Hospital, Vellore. This study was approved 
by the VIT Institutional Human Ethical Committee. 
Inform consent was taken from the patients and 
controls before involving them in this study. Blood 
samples from each patient were taken on day 2 of their 
normal menstrual cycle or progesterone-induced flow 
after an overnight fast. All the women in the control 
group were healthy and without any clinical symptoms 
of PCOS. 
 
Genotype determination of MTHFR gene C677T polymorphism 
DNA was extracted based on our lab protocol26 by 
collecting 2 mL venous blood from each patient, and 
the samples were subjected to store at 20°C. 
Amplification of DNA sample was carried using 
primers such 5-AGG ACG GTG CGG TGA GAG TG-
3 as the forward primer and 5-TGA AGG AGA AGG 
TGT CTG CGG GA-3 as a reverse primer by PCR in 
thermal cycling (Eppendorf Master Cycler gradient). 
The volume of each PCR mixture is of 20 μL (10 pmol 
from each primer, 5 µL water, master mix (Amplicon) 
10 µL. DNA sample (3 µL) was amplified for 35 cycles 
with initial denaturation for 5 min at 95C followed by 
denaturation at 95C for 45 s, annealing at 60C for 50 
s, the extension for one min at 72C and final extension 
for 10 min at 72C). The PCR products were run on 
electrophoresis on 2% agarose gel having 5 μL 
ethidium bromide (50 μg/μL), and final separated 
bands were visualized using a UV Transilluminator 
(Medox) which resulted in a 198 bp product. These 
products were digested using restriction enzyme (one 
unit) Hinf I for 2 h at 37°C. Digested PCR products 
then finally imperiled to electrophoresis on 3% agarose 
gel, then these bands were visualized under UV 
transilluminator (Medox), and bands were 
photographed by Gel Dock software. The expected 
genotypic polymorphism of the C allele is CT, CC, and 
TT were concluded in our study. 
 
Results and Discussion 
 
A major percent of the patient's samples obtained 
for this study belonged to the age group between 21-25 
years (Fig. 1A). The patient's clinical report showed 
that among all age groups, the PCOS patients aged 
between 21-25 years were observed to be overweight 
after calculating their BMI index (Fig. 1B). The 
majority of the population were diagnosed with the 
symptoms between the 21-25 age group and treatment 
for PCOS began after marriage due to infertility and 
patients diagnosed before that would be if any 
irregularities in the menstrual cycle (Fig. 1 C & D). No 
significant hereditary pass on of the syndrome can be 
stated with the data obtained from the survey of the 
patient symptoms of a syndrome-like Insulin problem, 
cardio problem, obesity, reproductive problems (Fig. 2). 
The hormone level of the patients involved in the study 
showed no major variation in the hormone profile from 
the normal range. The lower FSH value in few patients 
might be a possibility of ovarian failure. The FSH and 
LH ratio should be 1:1 for normal functioning as this 
gives an idea about a normal number of eggs present in 
the ovaries (Fig. 3). Elevation in the prolactin levels is 




a clear sign of amenorrhea. It is observed that levels are 
getting elevated with an increase in the age group (Fig. 3). 
It can be stated as the increased levels might be due  
to  stress  caused  in  the patients  due to the Syndrome  
outcome as it is a stress hormone too. The elevated 
TSH levels observed in a few might be a cause of 
decreased thyroid function (Fig. 3). Distributions of 
genotypic and allele frequency of MTHFR C677T 
polymorphism were associated with patients and 
controls. The allelic frequency designated for the  
C allele and T allele was 82.95 and 17.83% in patients,  
respectively, whereas it was 56.67 and 43.33%, 
respectively, in control groups (Table 1).  
 
In this study, we hypothesized that the association 
of MTHFR C677T polymorphism with PCOS in the 
South Indian cohort might be the risk feature for 
PCOS. Homozygous genotypes CC of MTHFR C677T 
gene polymorphism were found among patients. The 
proportion of genotypic distribution of MTHFR gene 
C677T polymorphism was suggestively different 
among patients and controls. In patients, CC genotype 
was found to be 74%, CT (16%), and TT (9.30%) 
correspondingly, and CC genotype was found to be 
44.4%, CT (24%), and TT (31%) statistically in 




Fig.1 — (A) Age group distribution of PCOS patients;  
(B) Comparison of body mass index; (C) Comparison of the time 
since the patients were diagnosed with PCOS; and (D) Marital 




Fig. 2 — Consanguinity and comorbidity associated with PCOS 




Fig. 3 — Hormone profiling of PCOS patients 
 
Table 1 — Genotype distribution and allele frequencies of MTHFR 
gene C677T polymorphism between PCOS patients and controls 
Group Distribution of genotypes Allele frequencies 
  CC CT TT C T 
Patients 74% 16% 12% 82.95% 17.83% 
Controls 44.40% 24% 31% 56.67% 43.33% 
 




patients as compared to controls. When the outcomes 
were assessed from the aspect of personal traits in 
patient groups, the prolactin rate was higher than FSH 
and LH, Similarly, for BMI values were seems to be 
higher among patients of age group 21-25 years. 
Karadeniz et al.20, who studied 30 PCOS patients and 28 
healthy controls, concluded that MTHFR gene C677T 
polymorphism is not associated with PCOS in the 
Turkish population. Also, Sung-Woo Choi et al.27 
perceived that the C677T polymorphism of the MTHFR 
gene is not interrelated to PCOS among Korean women 
population and concluded that the C677T polymorphism 
in MTHFR may have different impacts in among various 
ethnic groups. Rosen et al.18 concluded that the higher 
basal levels of FSH are linked to MTHFR C677T 
polymorphism may not distress ovarian stimulation. 
Bagos et al.28 revealed that MTHFR genotypes do not 
have a noteworthy correlation with the plasma Hcy 
(Homocysteine) levels in PCOS patients. Nevertheless, 
higher homocysteine levels in PCOS groups were 
witnessed than controls. In a study based on a meta-
analysis, no evidence for association of MTHFR gene 
polymorphism C677T with PCOS28 was observed. 
Palep-Singh et al.29 also compared MTHFR gene C677T 
polymorphism in South Asian and Caucasian 
populations with PCOS patients and concluded that the 
occurrence of homozygosity of TT677 and CC1298 
(7.2%) and (4.9%) in the Caucasians and (0%) and 
(16.6%) among South Asians. Also, in one of the other 
studies carried out by Madhu Jain et al.30 on 92 PCOS 
patients and 95 controls, they found a marginally higher 
prevalence of heterozygous (CT) genotype among 
PCOS patients. The association of MTHFR with ovarian 
cancer shows highly significant (P <0.001) variance in 
heterozygous (CT) condition of the C677T allele by 
computing odd ratio signifying that three-time increase 
the risk factor for the genetic predisposition of MTHFR 
"T" allele for the progress of ovarian carcinoma31.  
Wu et al.17, too established that the MTHFR C677T and 
A1298C polymorphisms might have an association with 
polycystic ovary syndrome in Chinese women; 
however, again, this study also suffers from the smaller 
sample size. Another study in the Chinese population 
reported that C677T nucleotide change is associated 
with Polycystic ovary syndrome in which CT and TT 
genotypes have increased risk for developing PCOS22. 
 
Conclusion 
In this study, CC Homozygous genotype was found 
to be higher when compared with heterozygous CT and 
Homozygous TT of MTHFR C677T gene polymorphism 
in PCOS Patients. The genotype distribution and allele 
frequencies of the C allele were found to be remarkably 
higher in patients than controls. Hence, MTHFR gene 
C677T polymorphism can be a possible genetic marker 
of PCOS development in the South Indian cohort. This 
finding may help the clinician for evaluation of PCOS. 
The different geographic area varies in gene pools of 
population. Therefore, additional studies can be done 
in diverse geographical regions. PCOS is a multi-
factorial disorder; it mainly has the associated with 
environment and lifestyle factors, and further research 
should confirm the association of MTHFR gene 
polymorphisms and environmental and lifestyle factors 
in PCOS cause. 
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